G C Farrell

1.8k total citations
46 papers, 1.4k citations indexed

About

G C Farrell is a scholar working on Epidemiology, Pharmacology and Hepatology. According to data from OpenAlex, G C Farrell has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 17 papers in Pharmacology and 14 papers in Hepatology. Recurrent topics in G C Farrell's work include Liver Disease Diagnosis and Treatment (17 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). G C Farrell is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Drug-Induced Hepatotoxicity and Protection (9 papers). G C Farrell collaborates with scholars based in Australia, United States and Sweden. G C Farrell's co-authors include Michael T. Murray, Kim Bell‐Anderson, Fahrettin Haczeyni, Christopher Liddle, J. Grierson, Philip I. Craig, Martin Weltman, Ishita Mehta, Jacob George and Maria Almira Correia and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

G C Farrell

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G C Farrell Australia 24 635 562 383 288 228 46 1.4k
Kazuyoshi Kon Japan 20 778 1.2× 500 0.9× 526 1.4× 386 1.3× 185 0.8× 52 1.6k
José M. Ladero Spain 27 330 0.5× 257 0.5× 742 1.9× 580 2.0× 386 1.7× 72 1.9k
Christopher D. Gove United Kingdom 16 303 0.5× 491 0.9× 355 0.9× 360 1.3× 75 0.3× 40 1.4k
A. M. Rappaport Canada 18 600 0.9× 633 1.1× 162 0.4× 217 0.8× 131 0.6× 44 1.6k
April D. Lake United States 17 870 1.4× 266 0.5× 160 0.4× 429 1.5× 365 1.6× 23 1.3k
Rhiannon N. Hardwick United States 22 724 1.1× 267 0.5× 269 0.7× 277 1.0× 534 2.3× 33 1.4k
P Bories France 13 512 0.8× 273 0.5× 435 1.1× 102 0.4× 244 1.1× 36 1.2k
Full‐Young Chang Taiwan 21 499 0.8× 468 0.8× 641 1.7× 192 0.7× 410 1.8× 50 1.6k
Behnam Saberi United States 18 592 0.9× 648 1.2× 535 1.4× 439 1.5× 235 1.0× 76 1.8k
Tin Aung Than United States 17 1.1k 1.7× 561 1.0× 549 1.4× 599 2.1× 183 0.8× 26 2.1k

Countries citing papers authored by G C Farrell

Since Specialization
Citations

This map shows the geographic impact of G C Farrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G C Farrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G C Farrell more than expected).

Fields of papers citing papers by G C Farrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G C Farrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G C Farrell. The network helps show where G C Farrell may publish in the future.

Co-authorship network of co-authors of G C Farrell

This figure shows the co-authorship network connecting the top 25 collaborators of G C Farrell. A scholar is included among the top collaborators of G C Farrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G C Farrell. G C Farrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farrell, G C & Narcissus Teoh. (2006). Management of chronic hepatitis B virus infection: a new era of disease control. Internal Medicine Journal. 36(2). 100–113. 41 indexed citations
2.
Dutta, Usha, Karen Byth, James G. Kench, et al.. (1999). Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case‐control study. Australian and New Zealand Journal of Medicine. 29(3). 300–307. 23 indexed citations
3.
Blouin, Robert A., G C Farrell, Costas Ioannides, K W Renton, & Charles O. Watlington. (1999). Impact of diseases on detoxication. Journal of Biochemical and Molecular Toxicology. 13(3-4). 215–218. 4 indexed citations
4.
Larcos, George, et al.. (1998). Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.. American Journal of Roentgenology. 171(2). 433–435. 75 indexed citations
5.
Farrell, G C. (1997). Therapy of hepatitis C: Interferon alfa-n1 trials. Hepatology. 26(Supplement 3). 96S–100S. 43 indexed citations
6.
Samarasinghe, Dev & G C Farrell. (1996). The Central Role of Sinusoidal Endothelial Cells in Hepatic Hypoxia–Reoxygenation Injury in the Rat. Hepatology. 24(5). 1230–1237. 40 indexed citations
7.
8.
Tapner, Michael, Christopher Liddle, Bryan Goodwin, Jacob George, & G C Farrell. (1996). Interferon γ Down–Regulates Cytochrome P450 3A Genes in Primary Cultures of Well–Differentiated Rat Hepatocytes. Hepatology. 24(2). 367–373. 43 indexed citations
9.
Weltman, Martin, et al.. (1995). Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment. Journal of Viral Hepatitis. 2(1). 39–45. 150 indexed citations
10.
Azer, Samy A., Michael T. Murray, G C Farrell, & Neill H. Stacey. (1993). Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats.. PubMed. 18(5). 1224–31. 19 indexed citations
11.
Lin, Ruby C.Y., et al.. (1992). Hepatitis C as the cause of chronic non‐A, non‐B hepatitis: High sensitivity of simultaneous measurement of core and non‐structural antibodies. Journal of Gastroenterology and Hepatology. 7(5). 459–462. 2 indexed citations
12.
Batey, Robert G, et al.. (1991). Non‐alcoholic steatohepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. Journal of Gastroenterology and Hepatology. 6(6). 585–590. 37 indexed citations
13.
Schoeman, Mark, Philip I. Craig, Christopher Liddle, et al.. (1990). Chronic non‐A, non‐B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Australian and New Zealand Journal of Medicine. 20(1). 56–62. 34 indexed citations
14.
Craig, Philip I., Ishita Mehta, M.E. Murray, et al.. (1990). Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver.. Molecular Pharmacology. 38(3). 313–318. 54 indexed citations
15.
Craig, Philip I., et al.. (1989). Rat but not human interferons suppress hepatic oxidative drug metabolism in rats. Gastroenterology. 97(4). 999–1004. 28 indexed citations
16.
17.
Farrell, G C, et al.. (1988). Source of raised serum estrogens in male rats with portal bypass.. Journal of Clinical Investigation. 81(1). 221–228. 30 indexed citations
18.
Farrell, G C. (1987). Drug metabolism in extrahepatic diseases. Pharmacology & Therapeutics. 35(3). 375–404. 33 indexed citations
19.
20.
Farrell, G C, et al.. (1970). Notes on the method for determining the heat stability of skim-milk powder.. Australian Journal of Dairy Technology. 25(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyoshi Kon Breakdown of academic impact, for papers by José M. Ladero Breakdown of academic impact, for papers by Christopher D. Gove Breakdown of academic impact, for papers by A. M. Rappaport Breakdown of academic impact, for papers by April D. Lake Breakdown of academic impact, for papers by Rhiannon N. Hardwick Breakdown of academic impact, for papers by P Bories Breakdown of academic impact, for papers by Full‐Young Chang Breakdown of academic impact, for papers by Behnam Saberi Breakdown of academic impact, for papers by Tin Aung Than
Rankless by CCL
2026